BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. (Q37420196)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. |
scientific article |
Statements
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma (English)
Anton Henssen
Theresa Thor
Andrea Odersky
Nicolai El-Hindy
Anneleen Beckers
Kristina Althoff
Simon Schäfers
Alexander Schramm
Ulrich Sure
Gudrun Fleischhack
Angelika Eggert
Johannes H Schulte
1 November 2013